Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| JOHNSON & JOHNSONJNJ · Entity 2722 | Vice Chair, Exec Committee | February 12, 2021 | February 18, 2021 |
| TAKEDA PHARMACEUTICAL CO LTDTAK · Entity 2662 | Director | July 01, 2026 | July 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
JOHNSON & JOHNSON
Report date February 12, 2021 · Filed February 18, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 275,547.3732 |
Ending reported balance
After 2021-02-12 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2021-02-12 · Exercise / conversion · Acquired 29,452 · Balance 284,254.3732 F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Row 2 · 2021-02-12 · Exercise / conversion · Acquired 5,610 · Balance 289,864.3732 F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Row 3 · 2021-02-12 · Tax withholding · Disposed 1,592 · Balance 288,272.3732 F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Row 4 · 2021-02-12 · Tax withholding · Disposed 12,725 · Balance 275,547.3732 F4: Shares withheld for payment of taxes upon vesting of Performance Share Units. |
| Performance Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-02-12 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-02-12 · Exercise / conversion · Disposed 29,452 · Balance 0 F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. |
| Restricted Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2021-02-12 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2021-02-12 · Exercise / conversion · Disposed 5,610 · Balance 0 F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting.
F2: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting.
F3: Shares withheld for payment of taxes upon vesting of Restricted Share Units.
F4: Shares withheld for payment of taxes upon vesting of Performance Share Units.
TAKEDA PHARMACEUTICAL CO LTD
Report date July 01, 2026 · Filed July 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 3,800 |
Reported balance
After 2026-07-01 transaction · row 1
1 source rowRow 1 · 2026-07-01 · Grant · Acquired 3,800 · Balance 3,800 F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. |
| Tax Obligation AwardSEC Table II · derivative / convertible security · Expires 2029-06-01 | Direct | 1,307 |
Reported balance
After 2026-07-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-07-01 · Grant · Acquired 1,307 · Balance 1,307 F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029.
F2: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2026 Filed Jul 6, 2026 22:11 UTC | TAKEDA PHARMACEUTICAL CO LTD TAK · Entity 2662 | GrantTax Obligation Award · Derivative | 1,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000266 · wk-form4_1783375873.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,307 Underlying: Ordinary Shares · 1,307 shares Expires 2029-06-01 F2 · derivative.exercise_price: Each Tax Obligation Award is the economic equivalent of one Ordinary Share that, upon vest, will be converted to a cash payment primarily to cover tax obligations at the then-current market price of the Ordinary Shares. Read SEC document |
| July 01, 2026 Filed Jul 6, 2026 22:11 UTC | TAKEDA PHARMACEUTICAL CO LTD TAK · Entity 2662 | GrantOrdinary Shares | 3,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001395064-26-000266 · wk-form4_1783375873.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,800 F1 · kind: Represents an award of restricted stock units (RSU). Each RSU represents a contingent right to receive one Ordinary Share, which will be converted into an equivalent number of American Depositary Shares following vest. The RSUs vest on June 1, 2029. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 5,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002853 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 29,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002853 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 29,452 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 12,725 | $165.55 | $2,106,623.75 |
DisclosureSEC source: 0001225208-21-002853 · doc4.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,547.3732 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 1,592 | $165.55 | $263,555.60 |
DisclosureSEC source: 0001225208-21-002853 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 288,272.3732 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 5,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002853 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 289,864.3732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Read SEC document |
| February 12, 2021 Filed Feb 18, 2021 00:09 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 29,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002853 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 284,254.3732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 12, 2018; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,605 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002093 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,605 Underlying: Common Stock · 5,605 shares Expires not disclosed F3 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F3 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 29,452 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002093 · doc4.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,452 Underlying: Common Stock · 29,452 shares Expires not disclosed F2 · derivative.exercise_price: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. F2 · derivative.expiration_date: On February 8, 2021, the Issuer's Compensation & Benefits Committe certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 12, 2018 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date. Read SEC document |
| February 08, 2021 Filed Feb 10, 2021 23:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 123,118 | $0.00 Strike: $164.62 | $0.00 |
DisclosureSEC source: 0001225208-21-002093 · doc4.xml · derivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 123,118 Underlying: Common Stock · 123,118 shares Expires 2031-02-08 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 11,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,695 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F2 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 27,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 27,686 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 12,022 | $150.46 | $1,808,830.12 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,799.2911 F4 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 4,079 | $150.46 | $613,726.34 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 266,821.2911 F3 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 11,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 270,900.2911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 13, 2020 Filed Feb 18, 2020 22:03 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 27,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002665 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 259,205.2911 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 13, 2017; converted into shares of Common Stock upon vesting. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,241 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002112 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,241 Underlying: Common Stock · 5,241 shares Expires not disclosed F4 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F4 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantPerformance Share Units · Derivative | 27,686 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-002112 · doc4.xml · derivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,686 Underlying: Common Stock · 27,686 shares Expires not disclosed F2 · derivative.exercise_price: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date F3 · derivative.expiration_date: On February 10, 2020, the Issuer's Compensation & Benefits Committee certified the performance factor applicable to Performance Share Units awarded to the reporting person on February 13, 2017 under the Issuer's Long-Term Incentive Plan. These Performance Share Units represent a contingent right to an equal number of shares of Common Stock or the cash value thereof, subject to the reporting person's continued service to the Issuer through the third anniversary of the initial award date Read SEC document |
| February 10, 2020 Filed Feb 13, 2020 00:32 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 134,064 | $0.00 Strike: $151.41 | $0.00 |
DisclosureSEC source: 0001225208-20-002112 · doc4.xml · derivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,064 Underlying: Common Stock · 134,064 shares Expires 2030-02-10 F1 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,606 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 9 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,606 Underlying: Common Stock · 5,606 shares Expires not disclosed F7 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F7 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 31,428 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 8 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 31,428 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F3 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 114,575 | $0.00 Strike: $131.94 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 7 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,575 Underlying: Common Stock · 114,575 shares Expires 2029-02-11 F6 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 15,884 | $131.94 | $2,095,734.96 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 5 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231,516.2242 F5 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 5,154 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 4 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,400.2242 F4 · shares: Shares earned due to performance factor of 116.4% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 31,428 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 242,246.2242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 12,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,571 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. F1 · derivative.expiration_date: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 4,320 | $132.00 | $570,240.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,818.2242 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 08, 2019 Filed Feb 13, 2019 02:15 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 12,571 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-19-002352 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Vice Chair, Exec Committee 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 215,138.2242 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted Share Units awarded under Issuer's Long-Term Incentive Plan on February 8, 2016; converted into shares of Common Stock upon vesting. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 155,342 | $0.00 Strike: $90.44 | $0.00 |
DisclosureSEC source: 0001225208-18-003484 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 155,342 shares Expires 2024-02-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 155,342 | $129.86 | $20,172,401.44 |
DisclosureSEC source: 0001225208-18-003484 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,564.3468 F1 · price: This transaction was executed in multiple trades at prices ranging from $129.435 to $130.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:46 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 155,342 | $90.44 | $14,049,130.48 |
DisclosureSEC source: 0001225208-18-003484 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 357,906.3468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 5,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002952 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,610 Underlying: Common Stock · 5,610 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 33,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002952 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,130 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantEmployee Stock Options (Right to Buy) · Derivative | 111,816 | $0.00 Strike: $129.51 | $0.00 |
DisclosureSEC source: 0001225208-18-002952 · doc4.xml · derivative · entry 4 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 111,816 Underlying: Common Stock · 111,816 shares Expires 2028-02-12 F4 · security: Awarded under Issuer's Long-Term Incentive Plan. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 19,564 | $129.51 | $2,533,733.64 |
DisclosureSEC source: 0001225208-18-002952 · doc4.xml · nonDerivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 202,564.3468 F3 · shares: Shares withheld for payment of taxes upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantCommon Stock | 11,927 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002952 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 222,128.3468 F2 · shares: Shares earned due to performance factor of 136% upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 12, 2018 Filed Feb 14, 2018 23:14 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 33,130 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002952 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,201.3468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Performance Share Units awarded under Issuer's Long-Term Incentive Plan on February 9, 2015; converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 13,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002812 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,252 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F1 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 4,584 | $128.18 | $587,577.12 |
DisclosureSEC source: 0001225208-18-002812 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 177,071.3468 F2 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| February 09, 2018 Filed Feb 13, 2018 23:55 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 13,252 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-18-002812 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,655.3468 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on February 9, 2015, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 21:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionRestricted Share Units · Derivative | 75,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-016825 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 75,492 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on October 31, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. F2 · derivative.expiration_date: Each Restricted Share Unit, awarded under Issuer's Long-Term Incentive Plan on October 31, 2014, represents a contingent right to receive one share of Common Stock, and vests on the third anniversary of the grant date. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 21:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Tax withholdingCommon Stock | 34,742 | $139.54 | $4,847,898.68 |
DisclosureSEC source: 0001225208-17-016825 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 168,400.416 F1 · shares: Shares withheld for payment of taxes upon vesting of Restricted Share Units. Read SEC document |
| October 31, 2017 Filed Nov 2, 2017 21:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 75,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-016825 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 203,142.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 15:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionEmployee Stock Options (Right to Buy) · Derivative | 102,692 | $0.00 Strike: $72.54 | $0.00 |
DisclosureSEC source: 0001225208-17-012890 · doc4.xml · derivative · entry 3 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 102,692 shares Expires 2023-01-13 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 15:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 102,692 | $133.14 | $13,672,628.53 |
DisclosureSEC source: 0001225208-17-012890 · doc4.xml · nonDerivative · entry 2 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,650.416 F1 · price: This transaction was executed in multiple trades at prices ranging from $133.00 to $133.38. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| July 24, 2017 Filed Jul 26, 2017 15:49 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionCommon Stock | 102,692 | $72.54 | $7,449,277.68 |
DisclosureSEC source: 0001225208-17-012890 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 230,342.416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 23:53 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | SaleCommon Stock | 22,000 | $117.29 | $2,580,274.40 |
DisclosureSEC source: 0001225208-17-003623 · doc4.xml · nonDerivative · entry 1 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,650.416 F1 · price: This transaction was executed in multiple trades at prices ranging from $117.23 to $117.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer, or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | GrantRestricted Share Units · Derivative | 11,695 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003494 · doc4.xml · derivative · entry 6 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,695 Underlying: Common Stock · 11,695 shares Expires not disclosed F5 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. F5 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Each Restricted Share Unit represents a contingent right to receive one share of Common Stock and vests three years after date of grant. Read SEC document |
| February 13, 2017 Filed Feb 16, 2017 11:01 UTC | JOHNSON & JOHNSON JNJ · Entity 2722 | Exercise / conversionPerformance Share Units · Derivative | 26,447 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003494 · doc4.xml · derivative · entry 5 Stoffels Paulus · CIK 0001559387 · Exec VP, Chief Scientific Off 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 26,447 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. F1 · derivative.expiration_date: Awarded under Issuer's Long-Term Incentive Plan. Performance Share Units awarded on February 10, 2014 converted into shares of Common Stock upon vesting of Performance Share Units and certification of performance results by the Board. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.